HAE logo

Haemonetics (HAE) Cash From Operations

Annual CFO

$181.75 M
-$91.31 M-33.44%

31 March 2024

HAE Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFO

$48.82 M
+$76.24 M+278.05%

28 September 2024

HAE Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFO

$84.94 M
-$50.30 M-37.19%

28 September 2024

HAE TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HAE Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-33.4%-50.8%-67.6%
3 y3 years+67.0%-21.8%-19.7%
5 y5 years+14.1%+63.3%-23.7%

HAE Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-33.4%+67.0%-50.8%+278.1%-68.9%at low
5 y5 years-33.4%+67.0%-50.8%+278.1%-68.9%at low
alltimeall time-33.4%+1065.1%-50.8%+278.1%-68.9%+2195.8%

Haemonetics Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
$48.82 M(-278.0%)
$84.94 M(-37.2%)
June 2024
-
-$27.42 M(-142.8%)
$135.24 M(-25.6%)
Mar 2024
$181.75 M(-33.4%)
-
-
Mar 2024
-
$64.08 M(<-9900.0%)
$181.75 M(-7.9%)
Dec 2023
-
-$540.00 K(-100.5%)
$197.28 M(-24.8%)
Sept 2023
-
$99.12 M(+419.4%)
$262.24 M(+4.8%)
June 2023
-
$19.09 M(-76.0%)
$250.15 M(-8.4%)
Mar 2023
$273.06 M(+58.5%)
$79.61 M(+23.6%)
$273.06 M(+4.4%)
Dec 2022
-
$64.42 M(-26.0%)
$261.50 M(+0.8%)
Sept 2022
-
$87.04 M(+107.3%)
$259.51 M(+20.2%)
June 2022
-
$41.99 M(-38.3%)
$215.94 M(+25.4%)
Mar 2022
$172.26 M(+58.3%)
$68.05 M(+9.0%)
$172.26 M(+62.9%)
Dec 2021
-
$62.43 M(+43.7%)
$105.76 M(-3.5%)
Sept 2021
-
$43.46 M(-2686.9%)
$109.62 M(+15.0%)
June 2021
-
-$1.68 M(-208.6%)
$95.31 M(-12.4%)
Mar 2021
$108.81 M(-31.2%)
$1.55 M(-97.7%)
$108.81 M(-29.2%)
Dec 2020
-
$66.29 M(+127.4%)
$153.66 M(-7.8%)
Sept 2020
-
$29.16 M(+146.8%)
$166.66 M(-0.4%)
June 2020
-
$11.81 M(-74.5%)
$167.40 M(+5.8%)
Mar 2020
$158.22 M(-0.7%)
$46.41 M(-41.5%)
$158.22 M(+19.5%)
Dec 2019
-
$79.28 M(+165.1%)
$132.45 M(+19.0%)
Sept 2019
-
$29.90 M(+1037.8%)
$111.33 M(-19.8%)
June 2019
-
$2.63 M(-87.3%)
$138.79 M(-12.9%)
Mar 2019
$159.28 M(-27.7%)
$20.64 M(-64.5%)
$159.28 M(-18.8%)
Dec 2018
-
$58.16 M(+1.4%)
$196.27 M(-3.6%)
Sept 2018
-
$57.36 M(+148.1%)
$203.50 M(-0.8%)
June 2018
-
$23.12 M(-59.9%)
$205.05 M(-6.9%)
Mar 2018
$220.35 M(+37.9%)
$57.63 M(-11.9%)
$220.35 M(+11.7%)
Dec 2017
-
$65.39 M(+11.0%)
$197.30 M(+5.4%)
Sept 2017
-
$58.90 M(+53.3%)
$187.11 M(+11.7%)
June 2017
-
$38.42 M(+11.1%)
$167.47 M(+4.8%)
Mar 2017
$159.74 M(+31.1%)
$34.58 M(-37.4%)
$159.74 M(-10.5%)
Dec 2016
-
$55.20 M(+40.6%)
$178.41 M(+15.1%)
Sept 2016
-
$39.27 M(+27.9%)
$155.06 M(+8.2%)
June 2016
-
$30.70 M(-42.4%)
$143.31 M(+17.6%)
Mar 2016
$121.86 M(-4.2%)
$53.25 M(+67.2%)
$121.86 M(-1.7%)
Dec 2015
-
$31.85 M(+15.8%)
$123.92 M(+4.2%)
Sept 2015
-
$27.51 M(+197.4%)
$118.96 M(-3.0%)
June 2015
-
$9.25 M(-83.3%)
$122.69 M(-3.5%)
Mar 2015
$127.18 M(-8.8%)
$55.30 M(+105.6%)
$127.18 M(+3.1%)
Dec 2014
-
$26.89 M(-13.9%)
$123.34 M(-13.0%)
Sept 2014
-
$31.24 M(+127.4%)
$141.74 M(+1.3%)
June 2014
-
$13.74 M(-73.3%)
$139.86 M(+0.2%)
Mar 2014
$139.52 M(+64.0%)
$51.47 M(+13.6%)
$139.52 M(+20.7%)
Dec 2013
-
$45.29 M(+54.3%)
$115.59 M(+22.6%)
Sept 2013
-
$29.36 M(+119.1%)
$94.27 M(-3.7%)
June 2013
-
$13.40 M(-51.3%)
$97.92 M(+15.1%)
Mar 2013
$85.07 M(-26.2%)
$27.54 M(+14.9%)
$85.07 M(-7.0%)
Dec 2012
-
$23.96 M(-27.4%)
$91.51 M(-5.0%)
Sept 2012
-
$33.01 M(+5870.0%)
$96.35 M(+8.6%)
June 2012
-
$553.00 K(-98.4%)
$88.74 M(-23.0%)
Mar 2012
$115.32 M(-6.6%)
$33.98 M(+18.0%)
$115.32 M(+1.6%)
Dec 2011
-
$28.80 M(+13.4%)
$113.48 M(-13.8%)
Sept 2011
-
$25.41 M(-6.4%)
$131.71 M(-3.9%)
June 2011
-
$27.13 M(-15.6%)
$137.06 M(+11.0%)
Mar 2011
$123.45 M(-5.5%)
$32.14 M(-31.7%)
$123.45 M(-3.6%)
Dec 2010
-
$47.03 M(+52.9%)
$128.00 M(+12.8%)
Sept 2010
-
$30.76 M(+127.4%)
$113.47 M(-4.2%)
June 2010
-
$13.53 M(-63.1%)
$118.49 M(-9.3%)
Mar 2010
$130.67 M(+12.3%)
$36.69 M(+12.9%)
$130.67 M(-5.1%)
Dec 2009
-
$32.50 M(-9.1%)
$137.69 M(+1.2%)
Sept 2009
-
$35.77 M(+39.2%)
$136.07 M(+6.1%)
June 2009
-
$25.71 M(-41.2%)
$128.23 M(+10.2%)
Mar 2009
$116.36 M(+49.8%)
$43.71 M(+41.5%)
$116.36 M(+11.3%)
Dec 2008
-
$30.88 M(+10.5%)
$104.57 M(+6.1%)
Sept 2008
-
$27.93 M(+101.8%)
$98.57 M(+27.5%)
June 2008
-
$13.84 M(-56.6%)
$77.33 M(-0.4%)
DateAnnualQuarterlyTTM
Mar 2008
$77.67 M(-7.1%)
$31.91 M(+28.3%)
$77.67 M(+11.2%)
Dec 2007
-
$24.88 M(+271.4%)
$69.85 M(-1.5%)
Sept 2007
-
$6.70 M(-52.8%)
$70.94 M(-11.6%)
June 2007
-
$14.18 M(-41.1%)
$80.23 M(-4.0%)
Mar 2007
$83.56 M(-2.4%)
$24.10 M(-7.2%)
$83.56 M(-2.4%)
Dec 2006
-
$25.97 M(+62.4%)
$85.59 M(-11.3%)
Sept 2006
-
$15.99 M(-8.7%)
$96.49 M(+5.6%)
June 2006
-
$17.51 M(-33.0%)
$91.37 M(+6.7%)
Mar 2006
$85.62 M(+20.2%)
$26.12 M(-29.1%)
$85.62 M(+4.1%)
Dec 2005
-
$36.87 M(+239.2%)
$82.24 M(+23.8%)
Sept 2005
-
$10.87 M(-7.6%)
$66.45 M(-9.6%)
June 2005
-
$11.76 M(-48.3%)
$73.51 M(+3.2%)
Mar 2005
$71.21 M(-7.2%)
$22.74 M(+7.9%)
$71.21 M(-8.1%)
Dec 2004
-
$21.08 M(+17.6%)
$77.48 M(-5.3%)
Sept 2004
-
$17.93 M(+89.5%)
$81.84 M(-2.2%)
June 2004
-
$9.46 M(-67.4%)
$83.67 M(+9.0%)
Mar 2004
$76.77 M(+63.4%)
$29.02 M(+14.1%)
$76.77 M(+17.4%)
Dec 2003
-
$25.44 M(+28.8%)
$65.41 M(+14.3%)
Sept 2003
-
$19.75 M(+670.6%)
$57.23 M(+18.6%)
June 2003
-
$2.56 M(-85.5%)
$48.27 M(+2.8%)
Mar 2003
$46.98 M(+41.0%)
$17.65 M(+2.2%)
$46.98 M(-1.1%)
Dec 2002
-
$17.27 M(+60.1%)
$47.51 M(+61.8%)
Sept 2002
-
$10.79 M(+750.9%)
$29.36 M(-11.2%)
June 2002
-
$1.27 M(-93.0%)
$33.07 M(-0.7%)
Mar 2002
$33.31 M(-41.4%)
$18.19 M(-2155.3%)
$33.31 M(-11.8%)
Dec 2001
-
-$885.00 K(-106.1%)
$37.77 M(-21.6%)
Sept 2001
-
$14.49 M(+858.0%)
$48.15 M(-10.6%)
June 2001
-
$1.51 M(-93.3%)
$53.88 M(-5.2%)
Mar 2001
$56.82 M(+6.3%)
$22.65 M(+138.5%)
$56.82 M(-3.6%)
Dec 2000
-
$9.49 M(-53.1%)
$58.93 M(+17.8%)
Sept 2000
-
$20.22 M(+354.5%)
$50.04 M(-1.5%)
June 2000
-
$4.45 M(-82.0%)
$50.81 M(-5.0%)
Mar 2000
$53.47 M(+58.6%)
$24.77 M(+4027.5%)
$53.47 M(+11.1%)
Dec 1999
-
$600.00 K(-97.1%)
$48.11 M(+7.8%)
Sept 1999
-
$21.00 M(+195.8%)
$44.61 M(+49.1%)
June 1999
-
$7.10 M(-63.4%)
$29.91 M(-11.3%)
Mar 1999
$33.71 M(+65.3%)
$19.41 M(-769.4%)
$33.71 M(-17.6%)
Dec 1998
-
-$2.90 M(-146.0%)
$40.90 M(-18.4%)
Sept 1998
-
$6.30 M(-42.2%)
$50.10 M(+32.9%)
June 1998
-
$10.90 M(-59.0%)
$37.70 M(+84.8%)
Mar 1998
$20.40 M(-56.5%)
$26.60 M(+322.2%)
$20.40 M(+36.0%)
Dec 1997
-
$6.30 M(-203.3%)
$15.00 M(-41.4%)
Sept 1997
-
-$6.10 M(-4.7%)
$25.60 M(-35.0%)
June 1997
-
-$6.40 M(-130.2%)
$39.40 M(-16.0%)
Mar 1997
$46.90 M(-14.4%)
$21.20 M(+25.4%)
$46.90 M(+34.0%)
Dec 1996
-
$16.90 M(+119.5%)
$35.00 M(-8.9%)
Sept 1996
-
$7.70 M(+600.0%)
$38.40 M(-21.1%)
June 1996
-
$1.10 M(-88.2%)
$48.70 M(-11.1%)
Mar 1996
$54.80 M(+251.3%)
$9.30 M(-54.2%)
$54.80 M(+2.8%)
Dec 1995
-
$20.30 M(+12.8%)
$53.30 M(+46.8%)
Sept 1995
-
$18.00 M(+150.0%)
$36.30 M(+50.0%)
June 1995
-
$7.20 M(-7.7%)
$24.20 M(+55.1%)
Mar 1995
$15.60 M(-42.2%)
$7.80 M(+136.4%)
$15.60 M(+0.6%)
Dec 1994
-
$3.30 M(-44.1%)
$15.50 M(-34.6%)
Sept 1994
-
$5.90 M(-521.4%)
$23.70 M(-1.3%)
June 1994
-
-$1.40 M(-118.2%)
$24.00 M(-11.1%)
Mar 1994
$27.00 M(-24.8%)
$7.70 M(-33.0%)
$27.00 M(-3.9%)
Dec 1993
-
$11.50 M(+85.5%)
$28.10 M(-7.9%)
Sept 1993
-
$6.20 M(+287.5%)
$30.50 M(-13.1%)
June 1993
-
$1.60 M(-81.8%)
$35.10 M(-2.2%)
Mar 1993
$35.90 M(+91.0%)
$8.80 M(-36.7%)
$35.90 M(-14.9%)
Dec 1992
-
$13.90 M(+28.7%)
$42.20 M(+73.7%)
Sept 1992
-
$10.80 M(+350.0%)
$24.30 M(+60.9%)
June 1992
-
$2.40 M(-84.1%)
$15.10 M(-19.7%)
Mar 1992
$18.80 M
$15.10 M(-477.5%)
$18.80 M(+408.1%)
Dec 1991
-
-$4.00 M(-350.0%)
$3.70 M(-51.9%)
Sept 1991
-
$1.60 M(-73.8%)
$7.70 M(+26.2%)
June 1991
-
$6.10 M
$6.10 M

FAQ

  • What is Haemonetics annual cash flow from operations?
  • What is the all time high annual CFO for Haemonetics?
  • What is Haemonetics annual CFO year-on-year change?
  • What is Haemonetics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Haemonetics?
  • What is Haemonetics quarterly CFO year-on-year change?
  • What is Haemonetics TTM cash flow from operations?
  • What is the all time high TTM CFO for Haemonetics?
  • What is Haemonetics TTM CFO year-on-year change?

What is Haemonetics annual cash flow from operations?

The current annual CFO of HAE is $181.75 M

What is the all time high annual CFO for Haemonetics?

Haemonetics all-time high annual cash flow from operations is $273.06 M

What is Haemonetics annual CFO year-on-year change?

Over the past year, HAE annual cash flow from operations has changed by -$91.31 M (-33.44%)

What is Haemonetics quarterly cash flow from operations?

The current quarterly CFO of HAE is $48.82 M

What is the all time high quarterly CFO for Haemonetics?

Haemonetics all-time high quarterly cash flow from operations is $99.12 M

What is Haemonetics quarterly CFO year-on-year change?

Over the past year, HAE quarterly cash flow from operations has changed by -$50.30 M (-50.75%)

What is Haemonetics TTM cash flow from operations?

The current TTM CFO of HAE is $84.94 M

What is the all time high TTM CFO for Haemonetics?

Haemonetics all-time high TTM cash flow from operations is $273.06 M

What is Haemonetics TTM CFO year-on-year change?

Over the past year, HAE TTM cash flow from operations has changed by -$177.29 M (-67.61%)